Teladoc Health concluded 2024 with a solid performance in Q4, despite a slight revenue decrease. Integrated Care showed growth and margin expansion, while BetterHelp faced challenges in a difficult operating environment. The company is focused on execution and cost structure improvements for 2025.
Fourth Quarter 2024 revenue decreased 3% year-over-year to $640.5 million.
Net loss for Fourth Quarter 2024 was $48.4 million, or $0.28 per share.
Adjusted EBITDA for Fourth Quarter 2024 decreased 35% year-over-year to $74.8 million.
Integrated Care segment revenue increased 2%, while BetterHelp segment revenue decreased 10% in Q4 2024.
For the full year 2025, Teladoc Health expects revenue between $2,468 million and $2,576 million, adjusted EBITDA between $278 million and $319 million, and net loss per share between ($1.10) and ($0.50). Free cash flow is projected to be between $190 million and $220 million. For the first quarter of 2025, revenue is expected to be between $608 million and $629 million, adjusted EBITDA between $47 million and $59 million, and net loss per share between ($0.40) and ($0.15).
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance